These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 8901229

  • 21. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 22. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
    Abe C.
    Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Drug-resistant Mycobacterium tuberculosis in Japan: a nationwide survey, 2002.
    Tuberculosis Research Committee (Ryoken).
    Int J Tuberc Lung Dis; 2007 Oct; 11(10):1129-35. PubMed ID: 17945071
    [Abstract] [Full Text] [Related]

  • 27. Surveillance of anti-tuberculosis drug resistance: results of the 1998/1999 proficiency testing in Italy. SMIRA (Italian Multicentre Study on Antituberculosis Drug Resistance) Study Group.
    Migliori GB, Ambrosetti M, Fattorini L, Penati V, Vaccarino P, Besozzi G, Ortona L, Saltini C, Orefici G, Moro ML, Lona E, Cassone A.
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):940-6. PubMed ID: 11055761
    [Abstract] [Full Text] [Related]

  • 28. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
    Al-Rubaish AM, Madania AA, Al-Muhanna FA.
    Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
    [Abstract] [Full Text] [Related]

  • 29. [Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
    Bercion R, Kuaban C.
    Bull Soc Pathol Exot; 1998 Sep; 91(3):199-202. PubMed ID: 9773189
    [Abstract] [Full Text] [Related]

  • 30. The prevalence of Mycobacterium tuberculosis drug resistance in New Caledonia, 1995-1996.
    Duval P, Levenes H, Boulahbal F.
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):219-23. PubMed ID: 10094323
    [Abstract] [Full Text] [Related]

  • 31. Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)--report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
    Drobniewski F, Rüsch-Gerdes S, Hoffner S, Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
    Clin Microbiol Infect; 2007 Dec; 13(12):1144-56. PubMed ID: 17727670
    [Abstract] [Full Text] [Related]

  • 32. Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007.
    Shulgina MV, Malakhov VN, Hoffner SE, Haile M, Wright A.
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1294-300. PubMed ID: 19793436
    [Abstract] [Full Text] [Related]

  • 33. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.
    Mokrousov I, Bhanu NV, Suffys PN, Kadival GV, Yap SF, Cho SN, Jordaan AM, Narvskaya O, Singh UB, Gomes HM, Lee H, Kulkarni SP, Lim KC, Khan BK, van Soolingen D, Victor TC, Schouls LM.
    J Microbiol Methods; 2004 Jun; 57(3):323-35. PubMed ID: 15134881
    [Abstract] [Full Text] [Related]

  • 34. [Comparison of susceptibility testing results of M. tuberculosis by different methods].
    Ding B, Zhao T, Gai Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):423-5. PubMed ID: 11778510
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the radiometric BACTEC 460 TB culture system and Löwenstein-Jensen medium for the isolation of mycobacteria in cutaneous tuberculosis and their drug susceptibility pattern.
    Aggarwal P, Singal A, Bhattacharya SN, Mishra K.
    Int J Dermatol; 2008 Jul; 47(7):681-7. PubMed ID: 18613873
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.
    Joloba ML, Whalen CC, Cave DM, Eisenach KD, Johnson JL, Okwera A, Morrissey A, Bajaksouzian S, Feagin J, Mugerwa R, Ellner J, Jacobs MR.
    East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of a modified antimycobacterial susceptibility test using Middlebrook 7H10 agar containing 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride.
    Lee S, Kong DH, Yun SH, Lee KR, Lee KP, Franzblau SG, Lee EY, Chang CL.
    J Microbiol Methods; 2006 Sep; 66(3):548-51. PubMed ID: 16563534
    [Abstract] [Full Text] [Related]

  • 39. [Analysis on quality control of drug susceptibility testing in the surveillance of drug resistance in tuberculosis in Henan].
    Xu J, Peng Y, Wang G.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):724-6. PubMed ID: 11480073
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.